CZ104397A3 - Způsob pěstování střevních bakterií se zvýšenými antigenními vlastnostmi a vakcina s obsahem těchto bakterií - Google Patents

Způsob pěstování střevních bakterií se zvýšenými antigenními vlastnostmi a vakcina s obsahem těchto bakterií Download PDF

Info

Publication number
CZ104397A3
CZ104397A3 CZ971043A CZ104397A CZ104397A3 CZ 104397 A3 CZ104397 A3 CZ 104397A3 CZ 971043 A CZ971043 A CZ 971043A CZ 104397 A CZ104397 A CZ 104397A CZ 104397 A3 CZ104397 A3 CZ 104397A3
Authority
CZ
Czechia
Prior art keywords
intestinal bacteria
bacteria
grown
campylobacter
group
Prior art date
Application number
CZ971043A
Other languages
Czech (cs)
English (en)
Inventor
John L. Pace
Richard I. Walker
Steven M. Frey
Original Assignee
Antex Biologics Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/538,543 external-priority patent/US5681736A/en
Application filed by Antex Biologics Inc. filed Critical Antex Biologics Inc.
Publication of CZ104397A3 publication Critical patent/CZ104397A3/cs

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/105Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/107Vibrio
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/045Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CZ971043A 1994-10-05 1995-10-04 Způsob pěstování střevních bakterií se zvýšenými antigenními vlastnostmi a vakcina s obsahem těchto bakterií CZ104397A3 (cs)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31840994A 1994-10-05 1994-10-05
US08/538,543 US5681736A (en) 1994-10-05 1995-10-03 Methods for producing enhanced antigenic shigella bacteria and vaccines comprising same
US08/538,545 US5679564A (en) 1994-10-05 1995-10-03 Methods for producing enhanced antigenic campylobacter bacteria and vaccines

Publications (1)

Publication Number Publication Date
CZ104397A3 true CZ104397A3 (cs) 1998-06-17

Family

ID=27405987

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ971043A CZ104397A3 (cs) 1994-10-05 1995-10-04 Způsob pěstování střevních bakterií se zvýšenými antigenními vlastnostmi a vakcina s obsahem těchto bakterií

Country Status (16)

Country Link
EP (1) EP0804542A4 (de)
JP (1) JP3394047B2 (de)
CN (1) CN1168693A (de)
AU (1) AU704283B2 (de)
BR (1) BR9509276A (de)
CA (1) CA2202027A1 (de)
CZ (1) CZ104397A3 (de)
FI (1) FI971403L (de)
HU (1) HUT77876A (de)
IL (1) IL115521A0 (de)
MX (1) MX9702431A (de)
NO (1) NO971519L (de)
NZ (1) NZ295907A (de)
PL (1) PL182700B1 (de)
SG (2) SG73510A1 (de)
WO (1) WO1996011258A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0792347B1 (de) * 1994-10-05 2005-11-23 Antex Biologics, Inc. Verfahren zur produktion von verstärkt antigen wirkenden heliobacter sp. und vakzine die diesen enthalten
EP2327720A1 (de) * 2003-05-30 2011-06-01 Intercell AG Enterokokken-Antigene
US20100074846A1 (en) * 2006-03-17 2010-03-25 Ellis John A Campylobacter Vaccines and Methods of use
EP2161035B1 (de) * 2007-05-28 2019-08-21 Daiichi Sankyo Company, Limited Ganzzellige imfpstoffzusammensetzung mit bordetella parapertussis
CN107513553B (zh) * 2017-09-18 2021-05-18 江南大学 一种筛选具有拮抗空肠弯曲杆菌感染功能的乳酸菌的方法
CN109633151B (zh) * 2018-12-26 2022-03-11 西北农林科技大学 一种肠炎沙门氏菌检测方法、试纸条及应用
WO2020141103A1 (en) 2018-12-31 2020-07-09 Bellevacc As Bacterial vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI932248L (fi) * 1991-09-18 1993-07-02 Amgen Inc Hepatit b-vaccinkomposition innehaollande ett gallsyrasalt

Also Published As

Publication number Publication date
NO971519D0 (no) 1997-04-03
CA2202027A1 (en) 1996-04-18
PL182700B1 (pl) 2002-02-28
EP0804542A1 (de) 1997-11-05
SG73510A1 (en) 2000-06-20
AU3956195A (en) 1996-05-02
EP0804542A4 (de) 1998-10-28
WO1996011258A1 (en) 1996-04-18
JPH10507347A (ja) 1998-07-21
FI971403A0 (fi) 1997-04-04
FI971403A7 (fi) 1997-06-04
JP3394047B2 (ja) 2003-04-07
HUT77876A (hu) 1998-09-28
AU704283B2 (en) 1999-04-15
SG73509A1 (en) 2000-06-20
NZ295907A (en) 1999-04-29
PL319580A1 (en) 1997-08-18
CN1168693A (zh) 1997-12-24
BR9509276A (pt) 1997-11-18
IL115521A0 (en) 1996-06-18
NO971519L (no) 1997-05-27
FI971403L (fi) 1997-06-04
MX9702431A (es) 1998-05-31

Similar Documents

Publication Publication Date Title
KR100422055B1 (ko) 항원성이보강된헬리코박터sp를생산하는방법과이를포함하는방법
Abraham et al. Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors
Eko et al. Characterization and immunogenicity of Vibrio cholerae ghosts expressing toxin-coregulated pili
KR19990022509A (ko) 라우소니아 인트라셀루라리스의 배양, 항-라우소니아 인트라셀룰라리스 백신 및 진단시약
EP0557467A1 (de) Diagnostisches testen von campylobacter jeguni oder coli-infektionen mit antigenen
US6051416A (en) Methods for producing enhanced antigenic Helicobacter sp.
SK280919B6 (sk) Spôsob výroby kompozitnej vakcíny proti črevnej infekcii spôsobenej enterotoxigénnymi baktériami e. coli u ľudí
CZ104397A3 (cs) Způsob pěstování střevních bakterií se zvýšenými antigenními vlastnostmi a vakcina s obsahem těchto bakterií
WO1996011257A9 (en) Methods for producing enhanced antigenic helicobacter sp. and vaccines comprising same
WO1996011258A9 (en) Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same
Yrios et al. Immune response of athymic and euthymic germfree mice to Campylobacter spp
Chaicumpa et al. Rapid detection of V. cholerae 01
US20030149255A1 (en) Bird diagnostics and treatments
Fang Intestinal Escherichia coli infections
WO2002030321A2 (en) Bird diagnostics and treatments
Lockman Motility and adherence as Salmonella typhimurium virulence factors: The pathogenesis of fla, mot, andfim mutants in murine typhoid fever
Aziz Annotated bibliography on classical vibrio cholerae
Westerman Production and characterization of monoclonal antibodies specific for the lipopolysaccharide of Serpulina hyodysenteriae serotypes one through seven
Hauer Clostridium chauvoei
Kim Studies on Salmonella enteritidis: Epidemiologic, diagnostic, and prophylactic approaches to S. enteritidis infection

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic